SC
IDXX icon

Sierra Capital’s Idexx Laboratories IDXX Stock Holding History

Sierra Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$2K – 356
2022
Q4 		$2K Hold
5
– – ﹤0.01% 520
2022
Q3 		$2K Hold
5
– – ﹤0.01% 524
2022
Q2 		$2K Hold
5
– – ﹤0.01% 591
2022
Q1 		$3K Hold
5
– – ﹤0.01% 598
2021
Q4 		$3K Buy
+5
New +$3.14K ﹤0.01% 598

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sierra Capital's IDXX Position: Q1 2023 in Review

Sierra Capital sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 5 shares — an estimated $2K sold.

Sierra Capital first reported a position in IDXX in Q4 2021 and held it in 5 quarters. The position peaked at $3K in Q1 2022. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • Sierra Capital reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • Sierra Capital sold 5 Idexx Laboratories shares in Q1 2023, an estimated $2K.
  • Sierra Capital first reported a position in Idexx Laboratories in Q4 2021 and held it in 5 quarters.
  • Sierra Capital's Idexx Laboratories position peaked at $3K in Q1 2022.
  • 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Sierra Capital's 13F filing for Q1 2023, filed 1 May 2023.